Aigh Capital Management LLC Ardelyx, Inc. Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.59 - $1.44 $1.35 Million - $3.29 Million	-2,285,945 Reduced 60.58%	1,487,476 $1.77 Million
Q2 2022 Aug 12, 2022	BUY	$0.51 - $1.17 $335,997 - $770,818	658,819 Added 21.15%	3,773,421 $2.23 Million
Q1 2022 May 12, 2022	BUY	$0.65 - $1.18 $463,316 - $841,098	712,795 Added 29.68%	3,114,602 $3.33 Million
Q4 2021 Feb 10, 2022	BUY	$0.86 - $1.7 $2.07 Million - $4.08 Million	2,401,807 New	2,401,807 $2.64 Million

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.